Pacira BioSciences Inc (PCRX)
16.57
-0.03
(-0.18%)
USD |
NASDAQ |
Nov 01, 16:00
16.55
-0.02
(-0.12%)
After-Hours: 20:00
Pacira BioSciences Max Drawdown (5Y): 85.67% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 85.67% |
| September 30, 2024 | 85.67% |
| August 31, 2024 | 85.67% |
| July 31, 2024 | 76.27% |
| June 30, 2024 | 70.10% |
| May 31, 2024 | 70.10% |
| April 30, 2024 | 70.10% |
| March 31, 2024 | 70.10% |
| February 29, 2024 | 70.10% |
| January 31, 2024 | 70.10% |
| December 31, 2023 | 70.10% |
| November 30, 2023 | 70.10% |
| October 31, 2023 | 70.10% |
| September 30, 2023 | 70.10% |
| August 31, 2023 | 70.10% |
| July 31, 2023 | 70.10% |
| June 30, 2023 | 70.10% |
| May 31, 2023 | 70.10% |
| April 30, 2023 | 72.46% |
| March 31, 2023 | 74.39% |
| February 28, 2023 | 74.39% |
| January 31, 2023 | 75.81% |
| December 31, 2022 | 76.94% |
| November 30, 2022 | 76.94% |
| October 31, 2022 | 76.94% |
| Date | Value |
|---|---|
| September 30, 2022 | 76.94% |
| August 31, 2022 | 76.94% |
| July 31, 2022 | 76.94% |
| June 30, 2022 | 76.94% |
| May 31, 2022 | 76.94% |
| April 30, 2022 | 76.94% |
| March 31, 2022 | 76.94% |
| February 28, 2022 | 76.94% |
| January 31, 2022 | 76.94% |
| December 31, 2021 | 76.94% |
| November 30, 2021 | 76.94% |
| October 31, 2021 | 76.94% |
| September 30, 2021 | 76.94% |
| August 31, 2021 | 76.94% |
| July 31, 2021 | 76.94% |
| June 30, 2021 | 76.94% |
| May 31, 2021 | 76.94% |
| April 30, 2021 | 76.94% |
| March 31, 2021 | 76.94% |
| February 28, 2021 | 76.94% |
| January 31, 2021 | 76.94% |
| December 31, 2020 | 76.94% |
| November 30, 2020 | 76.94% |
| October 31, 2020 | 76.94% |
| September 30, 2020 | 76.94% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
70.10%
Minimum
May 2023
85.67%
Maximum
Aug 2024
75.59%
Average
76.94%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
| Cyclo Therapeutics Inc | 99.36% |
| Revance Therapeutics Inc | 93.78% |
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 97.38% |
| iBio Inc | 99.97% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -29.26 |
| Beta (5Y) | 0.8183 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 43.60% |
| Historical Sharpe Ratio (5Y) | -0.4288 |
| Historical Sortino (5Y) | -0.6478 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 22.71% |